로딩 중…
지수 로딩 중…
Xenon Pharmaceuticals Inc.
XENE· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
CA
CA$52.90-0.56%
2026-06-18
Price Chart
Xenon Pharmaceuticals Inc.+65.83%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $5.11B |
| Revenue | $0.00 |
| Net Income | $-383M |
| Total Assets | $1.39B |
| Net Assets | $1.34B |
| Value | |
| P/B | 3.82x |
| FCF Yield | -6.01% |
| Profitability | |
| ROE | -28.64% |
| ROA | -27.63% |
| Revenue Growth | -100.00% |
| Financial Health | |
| Debt Ratio | 3.66% |
| Total Debt | $7M |
| FCF | $-307M |
| Cash | $546M |
| Current Ratio | 27.79x |
| Performance | |
| 1Y Return | 65.83% |
| 1M Return | -2.13% |
| From 52W High | -17.28% |
| 1Y MDD | -21.03% |
| Trading | |
| Volume | 1,310,159 shares |
| Trading Value | $70M |
| Per Share | |
| EPS | $-4.36 |
| BPS | $7.34 |